MovDisordV3, Main, Merge, bibRecord, 003867

Excessive Dopamine Neuron Loss in Progressive Supranuclear Palsy

Identifieur interne : 003867 ( Main/Merge ); précédent : 003866; suivant : 003868

Excessive Dopamine Neuron Loss in Progressive Supranuclear Palsy

Auteurs : Karen E. Murphy [Australie] ; Tanya Karaconji [Australie] ; Craig D. Hardman [Australie] ; Glenda M. Halliday [Australie]

Source :

Movement disorders [ 0885-3185 ] ; 2008.

RBID : Pascal:08-0199373

Descripteurs français

Pascal (Inist)
- Maladie de Parkinson, Pathologie du système nerveux, Dopamine, Mort cellulaire, Mésencéphale, Neurone.

English descriptors

KwdEn :
- Cell death, Dopamine, Midbrain, Nervous system diseases, Neuron, Parkinson disease.

Abstract

Progressive supranuclear palsy (PSP) and Parkinson's disease (PD) differ in their response to dopaminergic replacement therapies, despite having a similar degree of neuronal degeneration in the dopaminergic substantia nigra. We observed more widespread dopamine neuron loss in the extranigral A10 midbrain cell groups in PSP compared with PD. These cell groups innervate subcortical and cortical regions and may be required for adequate response to levodopa therapy.

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 001298
to stream PascalFrancis, to step Curation: 001A21
to stream PascalFrancis, to step Checkpoint: 001259

Links to Exploration step

Pascal:08-0199373

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Excessive Dopamine Neuron Loss in Progressive Supranuclear Palsy</title>
<author><name sortKey="Murphy, Karen E" sort="Murphy, Karen E" uniqKey="Murphy K" first="Karen E." last="Murphy">Karen E. Murphy</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Prince of Wales Medical Research Institute</s1>
<s2>Randwick</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Prince of Wales Medical Research Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Karaconji, Tanya" sort="Karaconji, Tanya" uniqKey="Karaconji T" first="Tanya" last="Karaconji">Tanya Karaconji</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Anatomy, School of Medical Sciences, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<placeName><settlement type="city">Sydney</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hardman, Craig D" sort="Hardman, Craig D" uniqKey="Hardman C" first="Craig D." last="Hardman">Craig D. Hardman</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Anatomy, School of Medical Sciences, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<placeName><settlement type="city">Sydney</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M." last="Halliday">Glenda M. Halliday</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Prince of Wales Medical Research Institute</s1>
<s2>Randwick</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Prince of Wales Medical Research Institute</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">08-0199373</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0199373 INIST</idno>
<idno type="RBID">Pascal:08-0199373</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001298</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001A21</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001259</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Murphy K:excessive:dopamine:neuron</idno>
<idno type="wicri:Area/Main/Merge">003867</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Excessive Dopamine Neuron Loss in Progressive Supranuclear Palsy</title>
<author><name sortKey="Murphy, Karen E" sort="Murphy, Karen E" uniqKey="Murphy K" first="Karen E." last="Murphy">Karen E. Murphy</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Prince of Wales Medical Research Institute</s1>
<s2>Randwick</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Prince of Wales Medical Research Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Karaconji, Tanya" sort="Karaconji, Tanya" uniqKey="Karaconji T" first="Tanya" last="Karaconji">Tanya Karaconji</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Anatomy, School of Medical Sciences, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<placeName><settlement type="city">Sydney</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hardman, Craig D" sort="Hardman, Craig D" uniqKey="Hardman C" first="Craig D." last="Hardman">Craig D. Hardman</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Anatomy, School of Medical Sciences, University of New South Wales</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<placeName><settlement type="city">Sydney</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M." last="Halliday">Glenda M. Halliday</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Prince of Wales Medical Research Institute</s1>
<s2>Randwick</s2>
<s3>AUS</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Prince of Wales Medical Research Institute</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cell death</term>
<term>Dopamine</term>
<term>Midbrain</term>
<term>Nervous system diseases</term>
<term>Neuron</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du   système nerveux</term>
<term>Dopamine</term>
<term>Mort cellulaire</term>
<term>Mésencéphale</term>
<term>Neurone</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Progressive supranuclear palsy (PSP) and Parkinson's disease (PD) differ in their response to dopaminergic replacement therapies, despite having a similar degree of neuronal degeneration in the dopaminergic substantia nigra. We observed more widespread dopamine neuron loss in the extranigral A10 midbrain cell groups in PSP compared with PD. These cell groups innervate subcortical and cortical regions and may be required for adequate response to levodopa therapy.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
</country>
<settlement><li>Sydney</li>
</settlement>
</list>
<tree><country name="Australie"><noRegion><name sortKey="Murphy, Karen E" sort="Murphy, Karen E" uniqKey="Murphy K" first="Karen E." last="Murphy">Karen E. Murphy</name>
</noRegion>
<name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M." last="Halliday">Glenda M. Halliday</name>
<name sortKey="Hardman, Craig D" sort="Hardman, Craig D" uniqKey="Hardman C" first="Craig D." last="Hardman">Craig D. Hardman</name>
<name sortKey="Karaconji, Tanya" sort="Karaconji, Tanya" uniqKey="Karaconji T" first="Tanya" last="Karaconji">Tanya Karaconji</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003867 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003867 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     Pascal:08-0199373
   |texte=   Excessive Dopamine Neuron Loss in Progressive Supranuclear Palsy
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Excessive Dopamine Neuron Loss in Progressive Supranuclear Palsy

Excessive Dopamine Neuron Loss in Progressive Supranuclear Palsy

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri